Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

January 24, 2012

Include Russia and Eastern Europe for Successful Clinical Trials

Keynote Speaker for this Event:
  • David Passov, CEO, ClinStar    Learn More
  • Include Russia and Eastern Europe for Successful Clinical Trials

    The paradigm of traditional drug development is shifting as more and more biopharmaceutical organizations look to emerging markets to reduce their clinical study timelines, and hence overall development costs, through more effective patient enrollment.

    For many, the enticement for conducting clinical trials in emerging markets is over shadowed by the fear of prolonged study start-up times, unknown regulation and logistics requirements and political uncertainty.

    During this presentation, ClinStar CEO David Passov will explore how to effectively navigate these challenges in Russia and parts of Eastern Europe (EE) and demonstrate how these countries are not only effective in rescue trials but should be included as an integral part of your initial study plans.

    Mr. Passov will:

    • Discuss characteristics and classification of “Emerging” vs “Emerged” for EE geographies
    • Consider why Russia and parts of EE are optimal for conducting clinical trials compared to other emerging countries
    • Discuss how to successfully navigate cultural differences and regulatory changes in the region in order to achieve expedited approval timelines and recruitment
    • Present case studies outlining the operational and opportunity cost savings of conducting trials in these fast enrolling geographies

      Register Today!


      Pharma and Biotech employees, more specifically anyone within these organizations who are clinical outsourcing or procurement decision makers, part of clinical teams

      Register Today!


      David Passov, CEO, ClinStar

      David Passov was born in Estonia when it was part of the former Soviet Union. He attended Tartu University Medical School in Estonia prior to moving to the US in 1993. He received a degree in biology from Boston College and following a short basic science research tenure at Massachusetts General Hospital’s neuroscience department entered the biopharmaceutical industry in 1996.

      Since that time, Mr. Passov has held positions in clinical operations, project management, market research, business development and commercial operations at various small and large US-based CROs. He also received an MBA from the Executive MBA Program at Northeastern University (Boston, MA) in 2002. Mr. Passov joined ClinStar in 2005. He is a native Russian speaker and spends the majority of his time residing in Moscow managing ClinStar’s offices in Russia and Ukraine.


      ClinStar is a leading CRO in emerging markets with extraordinarily fast patient enrollment, higher quality and passion for customer service.

      ClinStar, headquartered in San Francisco, California, is a contract research organization (CRO) that manages Phase I-IV clinical research trials in Russia, Ukraine, Belarus and the Baltic States. We are one of the oldest and most well established CROs in our region with more than 280 professionals based in our offices in Moscow, St. Petersburg, Kiev and Minsk as well as regionally throughout Russia and other parts of Eastern Europe.

      From regulatory submissions to clinical affairs to medical monitoring to drug storage and distribution, we offer fully integrated services for managing your trials in Russia, Ukraine and other regions of Eastern Europe. We are best known as a Western CRO in Eastern Europe providing faster patient recruitment and higher quality data than that provided in the West.

      Register Today!
      Copyright © 2016-2017 Honeycomb Worldwide Inc.